Skip to content

Clinical trials

Phase 2/3 Carcinoma, Non-Small-Cell Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2/3 Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20053
20061
20074
20081
20092
20101
20115
20121
20134
20144
20156
20162
20173
20182
20191
20204
20213
20225
20233
20243
20258
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting19
Unknown status16
Terminated10
Active, not recruiting9
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intergroupe Francophone de Cancerologie Thoracique3
SWOG Cancer Research Network3
Shanghai Chest Hospital3
AbbVie2
Cancer Research UK2
Chang Gung Memorial Hospital2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Hoffmann-La Roche2
NCIC Clinical Trials Group2
National Cancer Institute (NCI)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung79
Lung Neoplasms21
Neoplasms6
Brain Neoplasms4
Adenocarcinoma of Lung3
Colorectal Neoplasms3
Adenocarcinoma, Bronchiolo-Alveolar2
Anorexia2
Carcinoma, Squamous Cell2
Erdheim-Chester Disease2

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.